GUAIFENESIN
GUAIFENESIN
GUAIFENESIN
GUAISIN 60mL
100mg/5mL Elixir
Oral
Expectorant
Description:
Guaifenesin is an expectorant of the Propanediol derivatives. It has an IUPAC name
of 3-(2-methoxyphenoxy) propane-1,2-diol and a chemical name of C10H14O4.
Guaisin is an elixir with clear, orange color and a sweet orange flavour.
Formulation:
5mL of Guaisin elixir contains 100mg if the active ingredient Guaifenesin.
Pharmacokinetics:
Guaifenesin is rapidly absorbed in the GI tract. It is rapidly hydrolysed in which 60%
in seven hours and excreted in the urine. It has a Half-life of approximately 1 hour.
Pharmacodynamics:
Guaifenesin is an expectorant and functions by increasing the output of
phlegm/sputum and bronchial secretions by reducing the surface tension and
adhesiveness. Ciliary action and a more productive and less frequent cough is
exhibited with the increased flow of less viscous secretions.
Indication:
For the treatment of cough as an expectorant to relieve cough by promoting the
secretion of sputum in the air passages.
Recommended Dose:
Age
Recommended
Dose
Under 2 years
Consult a
Physician.
2-6 yrs.
50-100 mg every 4
hours, not exceeding
600 mg in 24 hours.
-1 teaspoon.
Children 6 to <12
100-200 mg every 4
hours, not exceeding
1200 mg in 24 hours.
1-2 teaspoons.
200-400 mg every 4
hours, not exceeding
2400mg in 24 hours.
2-4 teaspoons
Mode of Administration:
Guaisin is administered orally.
Contraindications:
Contraindicated to patients who are hypersensitive to Guaifenesin.
Warning and Precautions:
If symptoms persist, consult a physician.
Drug Interactions:
Guaifenesin has been shown to have interaction with 5-hydorxyindoleacetic acid (5HIAA) and vanilmandelic acid (VMA).
Pregnancy and Lactation:
Pregnancy Category: C
Guaifenesin is only recommended for pregnant use if the benefit outweighs risks.
Special precaution is recommended when administering Guaifenesin to lactating
women.
Adverse Effects:
Reported adverse effect of the intake of Guaifenesin, in large doses include:
Gastrointestinal discomfort, nausea and vomiting.
Overdose:
Nausea and vomiting may occur, discontinue medication and seek medical help
immediately.
Storage:
Protect from light, heat and moisture. Store at a room temperature between 15 to 30
degrees Celsius.
Dosage Forms:
Guaifenesin products are available in liquids/syrups and Immediate or sustained
release tablets.
Caution:
Manufactured by:
CIAT Pharmaceuticals
Note: [Place Address here]
Market Authorization Holder:
Note: [Name and Address here]
Registration Number:
Date of Revision:
1/06/17
http://iranuptodate.ir/contents/mobipreview.htm?15/46/16101?
source=see_link#F177606
https://pubchem.ncbi.nlm.nih.gov/compound/guaifenesin#section=HumanToxicity-Excerpts
https://www.drugs.com/cdi/guaifenesin-dm-elixir.html
https://www.drugs.com/monograph/guaifenesin.html